Sapient Launches Tumor Protein Mapping Platform to Characterize Functional Biology Across Critical Dimensions in Human Tumors

Introducing SurfaceSeek™, SignalingSeek™, ImmuneSeek™, and ResistanceSeek™ – optimized for fresh & FFPE human tumors.

SurfaceSeek™: Identify druggable tumor cell surface proteins

Directly measure proteins that are truly accessible on the tumor cell surface, enabling confident target identification.

SignalingSeek™: Measure functional tumor signaling pathways

Directly measure phosphorylation-driven signaling activity in human tumors to characterize functional pathway activation.

ImmuneSeek™: Quantify the functional tumor immune proteome

Directly measure immune cell states & signaling pathways in human tumors to characterize immune activity & response.

ResistanceSeek™: Quantify cellular resistance pathways in human tumors

Directly measure protein networks that drive therapeutic resistance in human tumors to characterize resistance mechanisms.

The Healthcare Theory Podcast: On the Future of Precision Medicine

Why proteins & metabolites give a more complete picture of biology, and how AI is finally unlocking this needed data.

Hypoxanthine—early biomarker of outcomes in an ovine model of neonatal hypoxic ischemic encephalopathy

This paper details the use of Sapient’s discovery metabolomics method to uncover an early biomarker of HIE.

Discovery Proteomics Services

Measure proteins & PTMs directly, at scale – covering 5,400+ proteins in plasma and 12,000+ in tissue matrices.

Targeted, Quantitative Protein Assays & Panels

Measure the proteins that matter most to your study – precisely, quantitatively, and at scale.

Metabolite Identification Services

How our comprehensive library of 13,000+ reference standards enhances the speed, quality & extent of metabolite identification.